Cart Icon0
Menu

Search from website

Monoclonal antibody to Influenza B, clone 1A2

 

Figure 1. Simply Blue Safe Stain SDS-PAGE analysis of monoclonal antibody to Influenza B, clone 1A2. 4-12% gradient gel is used for analysis. Lane 1. 0.8 µg monoclonal antibody to Influenza B, clone 1A2 (-DTT). Lane 2. Size marker. Lane 3. 0.8 µg monoclonal antibody to Influenza B, clone 1A2 (+DTT).

       

Figure 2. HPLC analytical SEC for final product.

       

Figure 3. HPLC analytical SEC after 3 freeze-thaw cycles.

     

1

2

 

Figure 4. Octet RED96e analysis, antibody was loaded on sensor for capture Flu b nucleocapsid protein (1) and H3N2 nucleocapsid protein (2).

                 

(for reference only; data shown are from a single production batch at release and may not be representative of other batches)

Select volume:

Quantity:

Catalogue #

R1-202-100

Name

Monoclonal antibody to Influenza B, clone 1A2

Target

Recombinant Influenza B Nucleocapsid protein

Target Description

Recombinant Influenza B nucleoprotein produced in Baculovirus-Insect Cells (B/Florida/4/2006).

Source

Human

Clonality

Human monoclonal

Clone

1A2

Class

hIgG1

Reactivity

Recognizes recombinant Influenza B NP from Influenza B/Florida/4/2006 (Yamagata lineage) and inactivated viruses Influenza B/Malaysia/2506/04 (Victoria lineage) and Influenza B/Florida/07/04 (Yamagata lineage). Clone 1A2 shows no cross-reactivity to recombinant NPs from Influenza A subtypes H1N1 and H3N2, nor to inactivated viruses Influenza A/New Caledonia/20/99 (H1N1) and Influenza A/Panama/2007/99 (H3N2). No cross-reactivity to tested human parainfluenza virus (HPIV Type 3), respiratory syncytial viruses (RSV A, RSV B) and human metapneumoviruses (hMPV 9 Type A1, hMPV 3 Type B1, hMPV 18 Type B2) lysates was observed.

Application

ELISA

Protocol

Monoclonal antibody working titer has to be established practically for each particular antigen and assay format

Concentration

1 mg/ml

Buffer

PBS pH 7.4

Related Products

Influenza B antibody clone 1A2 has been identified as a recommended capture antibody with clone 24C7 (cat# R1-208-100).

Shipping

Shipped with blue ice.

Storage

Store at +2…+8°C

Background

Influenza is an acute respiratory disease in mammals and domestic poultry that emerges from zoonotic reservoirs in aquatic birds and bats. Influenza viruses are enveloped negative-sense, single-stranded, fragmented RNA viruses that belong to the Orthomyxoviridae family. Influenza A and B cause annual epidemics and occasional pandemics of respiratory tract infections with a broad spectrum of disease severity ranging from asymptomatic to death. Influenza B viruses are classified into two circulating lineages: B/Victoria and B/Yamagata. Due to their low-fidelity RNA polymerase proofreading capabilities, Influenza viruses have a high mutation rate and are in a constant state of evolution. Influenza nucleoproteins (NP) that coat viral RNA are more conserved compared to surface proteins like HA and NA and are therefore the most common targets of commercially available influenza diagnostics.

This product is for research use only

TECHNICAL ASSISTANCE

Please refer any technical questions to

technical.support@icosagen.com

Our locations

United States Office

77 Geary St. 5th Floor
San Francisco, CA 94108

European Office

Eerika tee 1
Õssu, Kambja vald
Tartu maakond 61713
Estonia
+372 737 7070
Shopping Cart